← Open Payments lookup

NPI 1982384780: Open Payments

NPI 1982384780. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$253 in 13 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $220 · 2025 $253

Food & beverage: $253
CompanyPaymentsAmount
Novo Nordisk Inc4$85
ABBVIE INC.2$43
GlaxoSmithKline, LLC.2$38
PFIZER INC.2$38
AstraZeneca Pharmaceuticals LP2$34
Kowa Pharmaceuticals America, Inc.1$14

Products named: QULIPTA, SHINGRIX, ELIQUIS, Wegovy, AIRSUPRA, BREZTRI, ZORYVE.